Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial
Gespeichert in:
| Veröffentlicht in: | International journal of cancer 2013, Vol.132 (7), p.1581-1591 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1591 |
|---|---|
| container_issue | 7 |
| container_start_page | 1581 |
| container_title | International journal of cancer |
| container_volume | 132 |
| creator | ZEESTRATEN, Eliane C. M SPEETJENS, Frank M OOSTENDORP, Jaap FATHERS, Lorraine M DRIJFHOUT, Jan W DE VELDE, Cornelis J. H. Van KUPPEN, Peter J. K DER BURG, Sjoerd H. Van MELIEF, Cornelis J. M WELTERS, Marij J. P SAADATMAND, Sepideh STYNENBOSCH, Linda F. M JONGEN, Rogier KAPITEIJN, Ellen GELDERBLOM, Hans NIJMAN, Hans W VALENTIJN, A. Rob P. M |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_26974622</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>26974622</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_269746223</originalsourceid><addsrcrecordid>eNqNzL9KBDEQx_EgCq5_3mEay8Uke7vL2R2iWFgIZ3-E7Cw3EpMwmRN8JBtBfAMfwGcyoqWFMDDN5_fdU43Ry7HV1vT7qtHa6nY03XCojkp50NqYXi8a9bKaJhJKEdIMFAV5Rk6x_XwDSSBbhNx37fr27uMVnpz3FBEYyy5IqbyeZ3QFJ8icpp3_q_T-DX-2Tqr0KSRGLy6Ad9EjQ3ZCGKVcwArytubAnBsDPlAkX5kwuXCiDmYXCp7-_mN1dn11f3nTZlcqmrm2qGwy06Pj540dluNisLb7r_sCSj1j9A</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial</title><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>ZEESTRATEN, Eliane C. M ; SPEETJENS, Frank M ; OOSTENDORP, Jaap ; FATHERS, Lorraine M ; DRIJFHOUT, Jan W ; DE VELDE, Cornelis J. H. Van ; KUPPEN, Peter J. K ; DER BURG, Sjoerd H. Van ; MELIEF, Cornelis J. M ; WELTERS, Marij J. P ; SAADATMAND, Sepideh ; STYNENBOSCH, Linda F. M ; JONGEN, Rogier ; KAPITEIJN, Ellen ; GELDERBLOM, Hans ; NIJMAN, Hans W ; VALENTIJN, A. Rob P. M</creator><creatorcontrib>ZEESTRATEN, Eliane C. M ; SPEETJENS, Frank M ; OOSTENDORP, Jaap ; FATHERS, Lorraine M ; DRIJFHOUT, Jan W ; DE VELDE, Cornelis J. H. Van ; KUPPEN, Peter J. K ; DER BURG, Sjoerd H. Van ; MELIEF, Cornelis J. M ; WELTERS, Marij J. P ; SAADATMAND, Sepideh ; STYNENBOSCH, Linda F. M ; JONGEN, Rogier ; KAPITEIJN, Ellen ; GELDERBLOM, Hans ; NIJMAN, Hans W ; VALENTIJN, A. Rob P. M</creatorcontrib><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken, NJ: Wiley-Blackwell</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Immunotherapy ; Medical sciences ; Pharmacology. Drug treatments ; Tumors</subject><ispartof>International journal of cancer, 2013, Vol.132 (7), p.1581-1591</ispartof><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26974622$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>ZEESTRATEN, Eliane C. M</creatorcontrib><creatorcontrib>SPEETJENS, Frank M</creatorcontrib><creatorcontrib>OOSTENDORP, Jaap</creatorcontrib><creatorcontrib>FATHERS, Lorraine M</creatorcontrib><creatorcontrib>DRIJFHOUT, Jan W</creatorcontrib><creatorcontrib>DE VELDE, Cornelis J. H. Van</creatorcontrib><creatorcontrib>KUPPEN, Peter J. K</creatorcontrib><creatorcontrib>DER BURG, Sjoerd H. Van</creatorcontrib><creatorcontrib>MELIEF, Cornelis J. M</creatorcontrib><creatorcontrib>WELTERS, Marij J. P</creatorcontrib><creatorcontrib>SAADATMAND, Sepideh</creatorcontrib><creatorcontrib>STYNENBOSCH, Linda F. M</creatorcontrib><creatorcontrib>JONGEN, Rogier</creatorcontrib><creatorcontrib>KAPITEIJN, Ellen</creatorcontrib><creatorcontrib>GELDERBLOM, Hans</creatorcontrib><creatorcontrib>NIJMAN, Hans W</creatorcontrib><creatorcontrib>VALENTIJN, A. Rob P. M</creatorcontrib><title>Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial</title><title>International journal of cancer</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Immunotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNzL9KBDEQx_EgCq5_3mEay8Uke7vL2R2iWFgIZ3-E7Cw3EpMwmRN8JBtBfAMfwGcyoqWFMDDN5_fdU43Ry7HV1vT7qtHa6nY03XCojkp50NqYXi8a9bKaJhJKEdIMFAV5Rk6x_XwDSSBbhNx37fr27uMVnpz3FBEYyy5IqbyeZ3QFJ8icpp3_q_T-DX-2Tqr0KSRGLy6Ad9EjQ3ZCGKVcwArytubAnBsDPlAkX5kwuXCiDmYXCp7-_mN1dn11f3nTZlcqmrm2qGwy06Pj540dluNisLb7r_sCSj1j9A</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>ZEESTRATEN, Eliane C. M</creator><creator>SPEETJENS, Frank M</creator><creator>OOSTENDORP, Jaap</creator><creator>FATHERS, Lorraine M</creator><creator>DRIJFHOUT, Jan W</creator><creator>DE VELDE, Cornelis J. H. Van</creator><creator>KUPPEN, Peter J. K</creator><creator>DER BURG, Sjoerd H. Van</creator><creator>MELIEF, Cornelis J. M</creator><creator>WELTERS, Marij J. P</creator><creator>SAADATMAND, Sepideh</creator><creator>STYNENBOSCH, Linda F. M</creator><creator>JONGEN, Rogier</creator><creator>KAPITEIJN, Ellen</creator><creator>GELDERBLOM, Hans</creator><creator>NIJMAN, Hans W</creator><creator>VALENTIJN, A. Rob P. M</creator><general>Wiley-Blackwell</general><scope>IQODW</scope></search><sort><creationdate>2013</creationdate><title>Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial</title><author>ZEESTRATEN, Eliane C. M ; SPEETJENS, Frank M ; OOSTENDORP, Jaap ; FATHERS, Lorraine M ; DRIJFHOUT, Jan W ; DE VELDE, Cornelis J. H. Van ; KUPPEN, Peter J. K ; DER BURG, Sjoerd H. Van ; MELIEF, Cornelis J. M ; WELTERS, Marij J. P ; SAADATMAND, Sepideh ; STYNENBOSCH, Linda F. M ; JONGEN, Rogier ; KAPITEIJN, Ellen ; GELDERBLOM, Hans ; NIJMAN, Hans W ; VALENTIJN, A. Rob P. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_269746223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Immunotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZEESTRATEN, Eliane C. M</creatorcontrib><creatorcontrib>SPEETJENS, Frank M</creatorcontrib><creatorcontrib>OOSTENDORP, Jaap</creatorcontrib><creatorcontrib>FATHERS, Lorraine M</creatorcontrib><creatorcontrib>DRIJFHOUT, Jan W</creatorcontrib><creatorcontrib>DE VELDE, Cornelis J. H. Van</creatorcontrib><creatorcontrib>KUPPEN, Peter J. K</creatorcontrib><creatorcontrib>DER BURG, Sjoerd H. Van</creatorcontrib><creatorcontrib>MELIEF, Cornelis J. M</creatorcontrib><creatorcontrib>WELTERS, Marij J. P</creatorcontrib><creatorcontrib>SAADATMAND, Sepideh</creatorcontrib><creatorcontrib>STYNENBOSCH, Linda F. M</creatorcontrib><creatorcontrib>JONGEN, Rogier</creatorcontrib><creatorcontrib>KAPITEIJN, Ellen</creatorcontrib><creatorcontrib>GELDERBLOM, Hans</creatorcontrib><creatorcontrib>NIJMAN, Hans W</creatorcontrib><creatorcontrib>VALENTIJN, A. Rob P. M</creatorcontrib><collection>Pascal-Francis</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZEESTRATEN, Eliane C. M</au><au>SPEETJENS, Frank M</au><au>OOSTENDORP, Jaap</au><au>FATHERS, Lorraine M</au><au>DRIJFHOUT, Jan W</au><au>DE VELDE, Cornelis J. H. Van</au><au>KUPPEN, Peter J. K</au><au>DER BURG, Sjoerd H. Van</au><au>MELIEF, Cornelis J. M</au><au>WELTERS, Marij J. P</au><au>SAADATMAND, Sepideh</au><au>STYNENBOSCH, Linda F. M</au><au>JONGEN, Rogier</au><au>KAPITEIJN, Ellen</au><au>GELDERBLOM, Hans</au><au>NIJMAN, Hans W</au><au>VALENTIJN, A. Rob P. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial</atitle><jtitle>International journal of cancer</jtitle><date>2013</date><risdate>2013</risdate><volume>132</volume><issue>7</issue><spage>1581</spage><epage>1591</epage><pages>1581-1591</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><cop>Hoboken, NJ</cop><pub>Wiley-Blackwell</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7136 |
| ispartof | International journal of cancer, 2013, Vol.132 (7), p.1581-1591 |
| issn | 0020-7136 1097-0215 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_26974622 |
| source | Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Antineoplastic agents Biological and medical sciences Immunotherapy Medical sciences Pharmacology. Drug treatments Tumors |
| title | Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase 1/11 clinical trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T15%3A15%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Addition%20of%20interferon-%CE%B1%20to%20the%20p53-SLP%C2%AE%20vaccine%20results%20in%20increased%20production%20of%20interferon-%CE%B3%20in%20vaccinated%20colorectal%20cancer%20patients:%20A%20phase%201/11%20clinical%20trial&rft.jtitle=International%20journal%20of%20cancer&rft.au=ZEESTRATEN,%20Eliane%20C.%20M&rft.date=2013&rft.volume=132&rft.issue=7&rft.spage=1581&rft.epage=1591&rft.pages=1581-1591&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E26974622%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |